SHAREHOLDER ALERT: WeissLaw LLP Investigates Ra Pharmaceuticals, Inc.


NEW YORK, Oct. 10, 2019 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Ra Pharmaceuticals, Inc. (“RARX” or the “Company”) (NASDAQ: RARX) in connection with the proposed acquisition of the Company by UCB S.A….


Author: HEDGE

Executive Editor and Founder of Hedge Was Founded in January 22, 2008. Learn more about HEDGEaccordingly